Comparison

DL-Homocysteine

Item no. CAPS-C09019-100mg
Manufacturer Capsid Biotechnology
CASRN 454-29-5
Amount 100 mg
Quantity options 100 mg 1 g
Category
Type Amino Acid Derivates
Specific against other
Smiles NC(CCS)C(O)=O
Available
Storage Conditions
3 years -20°C powder
Small Target
Transferase
Big Target
Metabolism
Information
DL-Homocysteine is a weak neurotoxin that affects the production of kynurenic acid (KYNA) in the brain. DL-Homocysteine inhibits the activity of both KYNA biosynthetic enzymes, kynurenine aminotransferases (KATs) I and II.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close